In addition, the RA-FLS proportion in the S phase was remarkably reduced, whereas significantly elevated in the G1 phase in the P38 inhibitor group, PPARγ agonist group, and Shentong Zhuyu Decoction group contrasted with the blank group (P < 0.05). This evidence concerns the gene PPARG and rheumatoid arthritis.